Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy
Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment serves customers in addressing larger patient populations with new curative treatments Enables suspension production of viral vectors up to 1,000-liter scale Project adds to company’s ambition to accelerate growth through investments in “Big 3” businesses, which includes plans…
